German drugmaker Merck KGaA aims to double its research and development productivity, outlining plans on Monday to average launching one new medicine or major new treatment indication every 18 months.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,